Profile data is unavailable for this security.
About the company
Shield Therapeutics plc is a United Kingdom-based commercial-stage specialty pharmaceutical company. The Company specializes in the development and commercialization of late-stage pharmaceuticals which address areas of unmet medical need. The Company's lead product, Feraccru/Accrufer (ferric maltol), is a stable, non-salt-based oral therapy for adults with iron deficiency with or without anemia. Ferric maltol is approved in the United States, European Union, United Kingdom and Switzerland for the treatment of iron deficiency with or without anemia in adults. Its pipeline product candidate, PT20, is an iron-based phosphate binder that has the potential to treat patients with hyperphosphatemia related to dialysis or non-dialysis dependent chronic kidney disease (CKD). PT20 has completed its Phase II pivotal study. Its subsidiaries include Shield Therapeutics (DE) GmbH, Shield TX (Switzerland) AG, Shield TX (UK) Limited, Phosphate Therapeutics Limited and Shield Therapeutics Inc.
- Revenue in GBP (TTM)1.52m
- Net income in GBP-19.34m
- Incorporated2015
- Employees23.00
- LocationShield Therapeutics PLC3rd FlBaltic Business Quarters, Abbott's HillGATESHEAD NE8 3DUnited KingdomGBR
- Phone+44 191 511 8500
- Websitehttps://www.shieldtherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ovoca Bio PLC | 0.00 | -4.42m | 7.76m | 10.00 | -- | 0.6826 | -- | -- | -0.0541 | -0.0565 | 0.00 | 0.1387 | 0.00 | -- | -- | 0.00 | -31.04 | -10.95 | -32.77 | -11.66 | -- | -- | -- | -- | 5.17 | -- | 0.00 | -- | -- | -- | -129.93 | -- | 69.52 | -- |
Genflow Biosciences PLC | -100.00bn | -100.00bn | 8.04m | -- | -- | 4,262.64 | -- | -- | -- | -- | -- | 0.00001 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9711 | -- | -- | -- | -- | -- | -- | -- |
Evgen Pharma PLC | 0.00 | -2.73m | 9.48m | 11.00 | -- | 1.03 | -- | -- | -0.0099 | -0.0099 | 0.00 | 0.0336 | 0.00 | -- | -- | 0.00 | -24.76 | -42.32 | -25.95 | -46.45 | -- | -- | -- | -6,869.07 | -- | -- | 0.00 | -- | -100.00 | -- | -2.09 | -- | -47.61 | -- |
Midatech Pharma PLC | 578.00k | -5.46m | 10.59m | 20.00 | -- | 0.9892 | -- | 17.89 | -0.0734 | -0.0734 | 0.0072 | 0.1062 | 0.0509 | -- | 0.7198 | 28,900.00 | -48.04 | -40.54 | -61.01 | -49.01 | -- | -- | -944.64 | -1,301.64 | -- | -- | 0.0683 | -- | 68.51 | -15.26 | 75.39 | -- | -25.19 | -- |
Proteome Sciences plc | 6.40m | 560.00k | 11.05m | 27.00 | 20.69 | -- | 11.59 | 1.73 | 0.0018 | 0.0018 | 0.0208 | -0.0086 | 0.6514 | 2.88 | 5.35 | 237,148.10 | 5.70 | -7.87 | -- | -- | 56.29 | 59.94 | 8.75 | -15.71 | 0.369 | 2.76 | 1.28 | -- | 7.91 | 13.33 | -75.59 | -- | 43.95 | -- |
Abingdon Health PLC | 5.64m | -12.85m | 11.26m | 151.00 | -- | 0.5157 | -- | 2.00 | -0.0949 | -0.0949 | 0.03 | 0.1794 | 0.1581 | 0.8421 | 0.6699 | 37,317.88 | -36.04 | -- | -49.56 | -- | -1.38 | -- | -228.02 | -- | 1.48 | -167.05 | 0.0572 | -- | 121.93 | -- | -106.69 | -- | -- | -- |
Oxford Biodynamics PLC | 176.00k | -6.63m | 13.80m | 39.00 | -- | 2.10 | -- | 78.40 | -0.0695 | -0.0695 | 0.0018 | 0.0655 | 0.0133 | -- | 0.1832 | 4,512.82 | -50.16 | -24.63 | -57.11 | -26.67 | -- | -- | -3,768.18 | -480.92 | 2.80 | -- | 0.4983 | -- | -25.22 | -20.75 | -53.64 | -- | 71.53 | -- |
Kanabo Group PLC | 73.00k | -4.55m | 13.96m | 0.00 | -- | 2.39 | -- | 194.08 | -0.0144 | -0.0144 | 0.0002 | 0.014 | 0.0228 | -- | 0.3296 | -- | -142.42 | -- | -153.70 | -- | 9.59 | -- | -6,234.25 | -- | 11.43 | -- | 0.00 | -- | -- | -- | -3,374.05 | -- | -- | -- |
Provexis plc | 479.46k | -283.34k | 14.97m | 2.00 | -- | 9.96 | -- | 32.38 | -0.0001 | -0.0001 | 0.0002 | 0.0007 | 0.6028 | 0.5587 | 4.05 | 239,730.00 | -37.93 | -96.20 | -26.38 | -55.13 | 89.01 | 89.81 | -62.92 | -133.98 | 6.32 | -- | 0.00 | -- | 45.23 | 40.70 | 16.05 | -- | -- | -- |
Shield Therapeutics PLC | 1.52m | -19.34m | 15.46m | 23.00 | -- | 0.3841 | -- | 10.27 | -0.0933 | -0.0933 | 0.0075 | 0.1901 | 0.0395 | 0.6503 | 0.856 | 66,043.48 | -50.26 | -25.36 | -54.23 | -27.62 | 35.48 | 86.93 | -1,272.94 | -207.40 | 4.62 | -- | 0.0038 | -- | -85.38 | 37.95 | -635.21 | -- | -8.25 | -- |
Genincode PLC | 1.15m | -4.14m | 15.57m | 20.00 | -- | 1.17 | -- | 13.91 | -0.0432 | -0.0432 | 0.012 | 0.1432 | 0.1309 | 34.89 | 3.56 | 57,700.00 | -46.98 | -- | -51.02 | -- | 51.39 | -- | -358.93 | -- | 18.00 | -- | 0.00 | -- | 20.11 | -- | -255.23 | -- | -- | -- |
IXICO PLC | 8.20m | 949.00k | 15.65m | 93.00 | 16.65 | 1.36 | 9.91 | 1.91 | 0.0195 | 0.0195 | 0.1661 | 0.2398 | 0.6088 | -- | 2.99 | 88,161.29 | 7.04 | 1.59 | 8.19 | 2.13 | 61.59 | 63.73 | 11.56 | 2.11 | -- | 23.00 | 0.0451 | 0.00 | -3.59 | 22.97 | 65.44 | -- | 145.81 | -- |
Hemogenyx Pharmaceuticals PLC | 0.00 | -5.10m | 15.92m | 10.00 | -- | 1.97 | -- | -- | -0.0081 | -0.0081 | 0.00 | 0.0084 | 0.00 | -- | -- | 0.00 | -91.34 | -96.46 | -112.36 | -120.13 | -- | -- | -- | -- | -- | -1.05 | 0.0012 | -- | -- | -- | -144.89 | -- | 34.08 | -- |
Diurnal Group PLC | 5.28m | -13.34m | 16.55m | 36.00 | -- | 0.5654 | -- | 3.21 | -0.0839 | -0.0839 | 0.0335 | 0.1769 | 0.1734 | 0.5198 | 7.80 | 146,722.20 | -43.79 | -43.08 | -50.20 | -50.33 | 83.13 | -- | -252.54 | -427.57 | 7.13 | -22.99 | 0.00 | -- | -30.76 | -- | -146.78 | -- | -- | -- |
MiLOC Group Limited | 514.74k | -543.61k | 17.17m | 6.00 | -- | -- | -- | 32.97 | -0.0064 | -0.0064 | 0.0059 | -0.0484 | 0.5467 | -- | 11.32 | -- | -104.65 | -118.75 | -- | -- | 16.96 | 38.24 | -191.43 | -156.87 | -- | -- | -- | -- | -75.86 | -14.62 | -156.85 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Hargreaves Lansdown Stockbrokers Ltd.as of 02 May 2022 | 13.40m | 6.20% |
Jupiter Asset Management Ltd.as of 30 Apr 2022 | 12.11m | 5.60% |
Hargreaves Lansdown Asset Management Ltd.as of 02 May 2022 | 7.00m | 3.24% |
JPMorgan Asset Management (UK) Ltd.as of 10 Apr 2018 | 6.24m | 2.89% |
Rahn+Bodmer Co.as of 02 May 2022 | 5.65m | 2.61% |
USS Investment Management Ltd.as of 19 Mar 2021 | 5.07m | 2.34% |
Chelverton Asset Management Ltd.as of 31 Dec 2021 | 4.50m | 2.08% |
BlackRock Investment Management (UK) Ltd.as of 02 May 2022 | 4.02m | 1.86% |
IG Markets Ltd.as of 02 May 2022 | 3.10m | 1.43% |
Jarvis Investment Management Ltd.as of 02 May 2022 | 2.82m | 1.30% |